Therapeutics

Immunotherapy (active)

Tools

Back to the Top
  • Study completed / Planned end date
  • Planned end date unavailable
  • Study aborted
Immunotherapy (active) 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
AADvac1
Phase 1, Phase 2
AN-1792
Phase 2
Affitope AD02
Phase 2
Amilomotide
Phase 2
Vanutide cridificar
Phase 2